Clinical Trials in Canada / NCT01471834
Active, not recruiting
Not applicable
Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
NCT01471834 · tracked via the Priya Life Science Canada tracker
Condition(s) studied
High Blood Pressure
Investigational drug(s) / intervention(s)
BAROSTIM NEO SystemMedical Management
Study summary
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Eligibility
Inclusion Criteria:
* Actively participating in the Neo Non-Randomized Hypertension Study.
* Have signed a revised approved informed consent form for continued participation in this study.
Exclusion Criteria:
* Treating physician decision that the subject should not continue with therapy.
Primary outcome measure(s)
- To access long-term adverse events in participants implanted with the BAROSTIM NEO System. — For the duration of the study, up to 10 years.
Ascertain the type, frequency, severity and timing of long-term adverse events in participants implanted with the device, while providing a viable treatment option to participants currently implanted with CVRx's BAROSTIM NEO System.
Trial sites (9)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Calgary | Calgary | Alberta | |
| University of Alberta - Edmonton | Edmonton | Alberta | |
| London-Lawson Health Research Institute | London | Ontario | |
| University Hospital Cologne | Cologn | Germany | |
| University Hospital Duesseldorf | Düsseldorf | Germany | |
| Goettingen-Georg August University | Göttingen | Germany | |
| Midizinische Hochschule Hannover | Hanover | Germany | |
| Klinkum St. George Leipzig | Leipzig | Germany | |
| Maastricht University | Maastricht | Netherlands |
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT01471834 on ClinicalTrials.gov ↗ ← All trials in Canada